亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        BCLC staging system and liver transplantation: From a stage to a therapeutic hierarchy

        2021-11-26 04:32:35QuirinoLiAlessndroVitle

        Quirino Li , , Alessndro Vitle

        a Hepato-biliary and Organ Transplant Unit, Department of Surgery, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy

        b Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

        The Barcelona Clinic Liver Cancer (BCLC) system was proposed in 1999 with the intent to improve a therapeutic algorithm for the management of patients with hepatocellular carcinoma (HCC) [1].Both the European and the American Guidelines on the Treatment of HCC have endorsed the BCLC as the standard staging algorithm with prognostic and therapeutic implications [ 2 , 3 ].

        The BCLC staging system stratifies HCC patients into five stages(0, A, B, C and D). According to the algorithm, liver transplantation(LT) is indicated only in patients in the stages BCLC 0 and A, special situations provided.

        However, some doubts have been risen on the real possibility to maintain a strict adherence of this standard system in the real clinical practice, mainly in the case of intermediate and advanced patients [4]. In the specific setting of LT, a large study based on the ITA.LI.CA database showed a survival benefit for patients with intermediate tumors (BCLC stages B-C) and advanced liver cirrhosis(BCLC stage D), regardless of the nodule number-size criteria, provided that macroscopic vascular invasion and extra-hepatic disease are absent [5].

        A recent study from Mainz further investigated this aspect [6].In the study, Otto et al. analyzed the data of 198 HCC patients who underwent LT. As for the BCLC classification, the staging was as follows: 0 = 5; A = 77; B = 41; C = 53; and D = 22. According to these results, LT was performed in 116/198 (58.6%) patients against BCLC recommendations. Moreover, surgery (n= 16), radiofrequency ablation (n= 15) and transarterial chemoembolization (n= 151) preceded LT in 182 (91.9%) patients. Also in this case, the everyday management of a patient waiting for LT did not follow the algorithm.

        Interestingly, the BCLC classification did neither impact survival(P= 0.796) nor recurrence (P= 0.693). Lastly, at multivariable Cox regression analysis, the BCLC algorithm was not an independent risk factor for the outcome, while the lack of response to pretreatment and initial alpha-fetoprotein values were.

        According to the observed results, the principal limitations of the BCLC look to be in their lack of flexibility and disregard of biological parameters into the model.

        Recently, new scoring systems have been proposed with the intent to overpass these limits. The Hong Kong Liver Cancer classification was developed based on the analysis of 3856 patients,showing a significantly better ability than the BCLC system to distinguish between patients with specific overall survival time[area under the curve (AUC) = 0.84 vs. 0.80]. More importantly, the Hong Kong criteria identified subsets of BCLC intermediate- and advanced-stage patients to be able to obtain improved survival outcomes when they were treated with more aggressive therapies comprehending LT [7].

        The ITA.LI.CA prognostic score based on 1196 (training cohort)and 648 (validation cohort) HCC patients showed a superior predictive performance after restaging the patients after any treatment, with an AUC = 0.745 in the validation cohort [8].

        Recently the new concept of "therapeutic hierarchy" has been proposed instead of the “stage hierarchy" of the BCLC system, with the attempt to increase the flexibility of the decision-making [9].In other terms, the treatment decision is hierarchically dictated by the efficacy of each therapy, with complete or partial independence from the tumor stage.

        In conclusion, the paradigm of “stage hierarchy” looksto betoo old for the routine clinical management of LT patients. A shift of this paradigm is on the way.

        Acknowledgments

        None.

        Credit authorship contribution statement

        Quirino Lai :Conceptualization, Data curation, Investigation,Writing - original draft, Writing –review & editing.Alessandro Vitale:Supervision, Data curation, Investigation, Writing - original draft.

        Funding

        None.

        Ethical approval

        Not needed.

        Competing interest

        No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

        国产精品女主播在线播放| 国产喷水在线观看| 国产高清a| 亚洲一级毛片免费在线观看| 国产女高清在线看免费观看| 日韩精品久久不卡中文字幕| 亚洲国产丝袜久久久精品一区二区| 日韩精品久久久久久免费| .精品久久久麻豆国产精品| 国产男女乱婬真视频免费| 美女脱掉内裤扒开下面让人插| 国产精品会所一区二区三区| 黄网站欧美内射| 国产真人无遮挡免费视频| 免费一区二区三区av| 午夜被窝精品国产亚洲av香蕉| 熟女体下毛毛黑森林| 免费看一级a女人自慰免费| 在线观看播放免费视频| 男性av天堂一区二区| 亚洲av永久中文无码精品综合| 无码精品a∨在线观看| 精品国产av 无码一区二区三区| 国产h视频在线观看网站免费| 亚洲最大不卡av网站| 久久久久国色av免费观看性色| 曰本女人与公拘交酡免费视频| 日韩肥熟妇无码一区二区三区| 色综合悠悠88久久久亚洲| 丁字裤少妇露黑毛| 亚洲精品有码在线观看| 午夜亚洲精品一区二区| 亚洲精品电影院| 男人和女人高潮免费网站 | 无码成人一区二区| 亚洲成人777| 亚洲视频在线免费观看一区二区| 欧美a级在线现免费观看| 国产精品 高清 尿 小便 嘘嘘 | 欧美精品videosse精子| 亚洲日韩欧美一区二区三区|